Core Viewpoint - Global health officials and organizations have refuted claims linking acetaminophen to autism, emphasizing the lack of conclusive evidence despite recent statements from President Trump [1][6][9]. Company Response - Kenvue, the company behind Tylenol, asserts that independent research shows no causal link between acetaminophen and autism, expressing concern over the potential health risks and confusion for expecting mothers [3]. - Kenvue plans to continue advising expecting mothers to consult healthcare providers before taking any over-the-counter medications [3]. Regulatory Actions - The FDA has initiated a label change for acetaminophen in Tylenol, suggesting potential risks associated with its use during pregnancy, while still acknowledging that it may be reasonable for pregnant women to use it in certain situations [4][5]. - The FDA has recommended that pregnant women use the lowest effective dose for the shortest duration if necessary [6]. International Health Organizations' Stance - The European Medicines Agency and other global health organizations maintain that acetaminophen is safe for treating pain or fever in pregnant women, based on rigorous scientific assessments [7][9]. - The World Health Organization has stated that while some observational studies suggest a possible association between prenatal acetaminophen exposure and autism, the evidence remains inconsistent and lacks replicability [8][9]. Criticism of Misinformation - Spain's health minister criticized Trump's claims, highlighting the importance of relying on scientific evidence and health authorities rather than misinformation [9].